Blinatumomab: a historical perspective.
Nagorsen D, Kufer P, Baeuerle PA, Bargou R.
Nagorsen D, et al.
Pharmacol Ther. 2012 Dec;136(3):334-42. doi: 10.1016/j.pharmthera.2012.07.013. Epub 2012 Aug 24.
Pharmacol Ther. 2012.
PMID: 22940266
Review.
For decades, chemotherapy has been the backbone for the treatment of patients with B cell malignancies. Depending on the individual disease, monoclonal antibodies, irradiation and/or hematopoietic stem cell transplantation are added. ...Here, we review how blinatumo …
For decades, chemotherapy has been the backbone for the treatment of patients with B cell malignancies. Depending on the indiv …